A citation-based method for searching scientific literature

Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni, Hiroshi Hiai, Wataru Mizunoya, Tohru Fushiki, Jens Juul Holst, Mitsuhiro Makino, Akira Tashita, Yukari Kobara, Yoshiharu Tsubamoto, Takayoshi Jinnouchi, Takahito Jomori, Yutaka Seino. Nat Med 2002
Times Cited: 610



Erina Joo, Norio Harada, Shunsuke Yamane, Toru Fukushima, Daisuke Taura, Kanako Iwasaki, Akiko Sankoda, Kimitaka Shibue, Takanari Harada, Kazuyo Suzuki, Akihiro Hamasaki, Nobuya Inagaki. Diabetes 2017
Times Cited: 43




List of shared articles



Times cited


Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective.
Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Nutrients 2021
3

GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Geke Aline Boer, Stacey N Keenan, Paula M Miotto, Jens Juul Holst, Matthew J Watt. Am J Physiol Endocrinol Metab 2021
1


The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Andreas F H Pfeiffer. Diabetes Obes Metab 2021
1

Medium-chain triglycerides inhibit long-chain triglyceride-induced GIP secretion through GPR120-dependent inhibition of CCK.
Yuki Murata, Norio Harada, Shigenobu Kishino, Kanako Iwasaki, Eri Ikeguchi-Ogura, Shunsuke Yamane, Tomoko Kato, Yoshinori Kanemaru, Akiko Sankoda, Tomonobu Hatoko,[...]. iScience 2021
0

Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?
Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, Yuichiro Yamada, Murielle M Véniant, David J Lloyd. Endocr Rev 2020
19

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease.
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, Lærke S Gasbjerg, Mikkel B Christensen, Filip K Knop. Peptides 2020
5


Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide-Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes.
William G Tharp, Dhananjay Gupta, Olga Sideleva, Carolyn F Deacon, Jens J Holst, Dariush Elahi, Richard E Pratley. Diabetes 2020
3


Cardiovascular biology of the GIP receptor.
Amanda A Greenwell, Jadin J Chahade, John R Ussher. Peptides 2020
3

Sexually dimorphic metabolic responses to exposure of a high fat diet during pregnancy, lactation and early adulthood in Gipr-/- mice.
Michael Kruse, Farnaz Keyhani-Nejad, Martin A Osterhoff, Andreas F H Pfeiffer. Peptides 2020
1

Pharmacological antagonism of the incretin system protects against diet-induced obesity.
Berit Svendsen, Megan E Capozzi, Jingjing Nui, Sarah A Hannou, Brian Finan, Jacqueline Naylor, Peter Ravn, David A D'Alessio, Jonathan E Campbell. Mol Metab 2020
14

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review.
Yusaku Mori, Takanori Matsui, Tsutomu Hirano, Sho-Ichi Yamagishi. Int J Mol Sci 2020
6


How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Ricardo J Samms, Matthew P Coghlan, Kyle W Sloop. Trends Endocrinol Metab 2020
23

Identification and characterization of adipose surface epitopes.
Yasuhiro Onogi, Ahmed Elagamy Mohamed Mahmoud Khalil, Siegfried Ussar. Biochem J 2020
4

Genetics of Obesity in East Asians.
Chang Sun, Peter Kovacs, Esther Guiu-Jurado. Front Genet 2020
2


Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects.
Renate Luzía Barbosa-Yañez, Mariya Markova, Ulrike Dambeck, Caroline Honsek, Jürgen Machann, Rita Schüler, Stefan Kabisch, Andreas F H Pfeiffer. Peptides 2020
0

Absence of GIP secretion alleviates age-related obesity and insulin resistance.
Yoshinori Kanemaru, Norio Harada, Satoko Shimazu-Kuwahara, Shunsuke Yamane, Eri Ikeguchi, Yuki Murata, Sakura Kiyobayashi, Tomonobu Hatoko, Nobuya Inagaki. J Endocrinol 2020
3

Insights into incretin-based therapies for treatment of diabetic dyslipidemia.
Kerstin Stemmer, Brian Finan, Richard D DiMarchi, Matthias H Tschöp, Timo D Müller. Adv Drug Deliv Rev 2020
6

Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.
Yukiko Fu, Kentaro Kaneko, Hsiao-Yun Lin, Qianxing Mo, Yong Xu, Takayoshi Suganami, Peter Ravn, Makoto Fukuda. Endocrinology 2020
6


Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
Yuki Murata, Norio Harada, Shunsuke Yamane, Kanako Iwasaki, Eri Ikeguchi, Yoshinori Kanemaru, Takanari Harada, Akiko Sankoda, Satoko Shimazu-Kuwahara, Erina Joo,[...]. Am J Physiol Endocrinol Metab 2019
3